Cancer immunotherapies with a switch (IMAGE)
Caption
When CAR-T cells recognise tumour antigens, a genetic switch activates an added gene. Researchers linked this switch to a gene producing a fluorescent protein, allowing them to track it turning on, off and on again.
Credit
IIT-Istituto Italiano di Tecnologia
Usage Restrictions
use with credit and caption
License
Original content